### Instruction: What is the sentiment of this tweet? Please choose an answer from {negative/neutral/positive} ### Human: BioTie North-American licensing partner Somaxon Pharmaceuticals started a phase II-III clinical study in patients suffering from pathological gambling and a pilot phase II study in nicotine addiction smoking cessation . ### Assistant: neutral.